U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07701369) titled 'Relevance of Artificial Intelligence-Assisted Echocardiography for Left Ventricular Ejectio... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy ... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2 arm parallel-group, double-blind, placebo... और पढ़ें
U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07700459) titled 'Exercise Prehabilitation in Congenital Heart Disease' on July 08. Brief Summary: Around 8-... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'Bepirovirsen Liver Biopsy study'. The following are the other relevant details related to the tria... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing BMS-986504 in Combination with Nab-paclitaxel a... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A randomised phase III trial of adjuvant cemiplimab in patients with resected stage II-IIIA NSCLC ... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyros... और पढ़ें
Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Ad... और पढ़ें